Search

1. Part D plans generally include drugs commonly used by dual eligibles: 2018

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018

Subject(s):

Drug Utilization
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Medicare Part D
United States
United States. Department of Health and Human Services
United States.

2. Opioid use in Medicare Part D remains concerning

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018

Subject(s):

Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
United States
United States. Department of Health and Human Services

3. Electronic prescribing of controlled substances among office-based physicians: 2017

Author(s):

Parasrampuria, Sonal, author
Blanco, Martín, author
Barker, Wesley, author

Publication:

Washington, DC : U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology, September 2019

Subject(s):

Controlled Substances
Electronic Prescribing -- statistics & numerical data
Practice Patterns, Physicians' -- statistics & numerical data
Prescription Drug Diversion -- prevention & control
Electronic Health Records
Medicare Part D
United States
United States. Department of Health and Human Services

4. Opioid use in Medicare Part D during the onset of the COVID-19 pandemic

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, February 2021

Subject(s):

Analgesics, Opioid
COVID-19
Government Regulation
Medicare Part D
United States
United States. Department of Health and Human Services

5. How do prescription drugs affect the use of other health services?

Author(s):

Wettstein, Gal, author

Publication:

Chestnut Hill, MA : Center for Retirement Research at Boston College, February 2018

Subject(s):

Facilities and Services Utilization
Medicare Part D
Prescription Drugs
United States

6. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, October 2017

Subject(s):

Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
United States
Centers for Medicare & Medicaid Services (U.S.)

7. An assessment of beneficiary knowledge of Medicare coverage options and the prescription drug benefit

Publication:

Washington, D.C. : AARP Public Policy Institute, c2006

Subject(s):

Choice Behavior
Decision Making
Health Knowledge, Attitudes, Practice
Insurance, Pharmaceutical Services
Medicare Part D
United States

8. Prescription drugs and Medicare Part D: a report on access, satisfaction, and cost

Publication:

Washington, D.C. : AARP Knowledge Management, c2007

Subject(s):

Drug Costs
Drug Prescriptions -- economics
Health Services Accessibility
Medicare Part D
Patient Satisfaction
United States

9. Doors to extra help: boosting enrollment in the Medicare Part D low-income subsidy

Publication:

Washington, D.C. : AARP Public Policy Institute, c2007

Subject(s):

Medicare Part D
Insurance, Pharmaceutical Services
Eligibility Determination
Health Services Accessibility
United States

10. Opioid overdoses and the limited treatment of opioid use disorder continue to be concerns for Medicare beneficiaries

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

Government Regulation
Medicare Part D
Opiate Overdose
Opioid-Related Disorders
United States